These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2061 related items for PubMed ID: 24603131

  • 21. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
    Quinn GP, Vadaparampil ST, Miree CA, Lee JH, Zhao X, Friedman S, Yi S, Mayer J.
    Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
    [Abstract] [Full Text] [Related]

  • 22. Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers.
    Tan YQ, Tan K, Zhang SP, Gong F, Cheng DH, Xiong B, Lu CF, Tang XC, Luo KL, Lin G, Lu GX.
    Hum Reprod; 2013 Sep; 28(9):2581-92. PubMed ID: 23847111
    [Abstract] [Full Text] [Related]

  • 23. Preimplantation genetic diagnosis for cancer predisposition syndromes.
    Spits C, De Rycke M, Van Ranst N, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K.
    Prenat Diagn; 2007 May; 27(5):447-56. PubMed ID: 17330926
    [Abstract] [Full Text] [Related]

  • 24. The clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study.
    Kakourou G, Kahraman S, Ekmekci GC, Tac HA, Kourlaba G, Kourkouni E, Sanz AC, Martin J, Malmgren H, Giménez C, Gold V, Carvalho F, Billi C, Chow JFC, Vendrell X, Kokkali G, Liss J, Steffann J, Traeger-Synodinos J.
    Hum Reprod; 2018 Mar 01; 33(3):520-530. PubMed ID: 29432583
    [Abstract] [Full Text] [Related]

  • 25. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May 01; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 26. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH, Zargar M, Warner E, Greenblatt EE, Lee E, Chan KKW, Wong WWL.
    Hum Reprod; 2020 Feb 29; 35(2):434-445. PubMed ID: 32099994
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth.
    Jasper MJ, Liebelt J, Hussey ND.
    Prenat Diagn; 2008 Apr 29; 28(4):292-8. PubMed ID: 18302307
    [Abstract] [Full Text] [Related]

  • 29. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K, Rubin LR, Werner-Lin A, Sagi M, Kemel Y, Stern R, Phillips A, Cholst I, Kauff N, Offit K.
    Cancer; 2012 Dec 15; 118(24):6270-7. PubMed ID: 22736296
    [Abstract] [Full Text] [Related]

  • 30. Motives and considerations regarding PGT in couples carrying a structural chromosomal abnormality: a qualitative exploration.
    De Krom G, Severijns Y, Vlieg WL, Arens YHJM, Van Golde RJT, De Die-Smulders CEM, Van Osch LADM.
    J Assist Reprod Genet; 2020 Jul 15; 37(7):1719-1727. PubMed ID: 32418135
    [Abstract] [Full Text] [Related]

  • 31. Attitudes of high-risk women toward preimplantation genetic diagnosis.
    Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S.
    Fertil Steril; 2009 Jun 15; 91(6):2361-8. PubMed ID: 18440521
    [Abstract] [Full Text] [Related]

  • 32. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
    Werner-Lin A, Rubin LR, Doyle M, Stern R, Savin K, Hurley K, Sagi M.
    Fam Syst Health; 2012 Jun 15; 30(2):166-80. PubMed ID: 22709328
    [Abstract] [Full Text] [Related]

  • 33. Individualized decision-making in IVF: calculating the chances of pregnancy.
    van Loendersloot LL, van Wely M, Repping S, Bossuyt PM, van der Veen F.
    Hum Reprod; 2013 Nov 15; 28(11):2972-80. PubMed ID: 23925394
    [Abstract] [Full Text] [Related]

  • 34. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP, van Tilborg TC, van Montfoort A, Smits L, Torrance HL, Meijer-Hoogeveen M, Broekmans F, Dreesen JCFM, Paulussen ADC, Tjan-Heijnen VCG, Homminga I, van den Berg MMJ, Ausems MGEM, de Rycke M, de Die-Smulders CEM, Verpoest W, van Golde R.
    J Assist Reprod Genet; 2017 Nov 15; 34(11):1475-1482. PubMed ID: 28831696
    [Abstract] [Full Text] [Related]

  • 35. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A, Fabiani M, Caroselli S, Poli M, Girardi L, Patassini C, Favero F, Cimadomo D, Vaiarelli A, Simon C, Rienzi LF, Ubaldi FM.
    Hum Reprod; 2021 Jun 18; 36(7):2050-2061. PubMed ID: 34021342
    [Abstract] [Full Text] [Related]

  • 36. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M, Iwase T, Takazawa Y, Takeshima N.
    Gan To Kagaku Ryoho; 2014 Nov 18; 41(11):1333-9. PubMed ID: 25434434
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C, Fabre R, Coupier I, Stoppa-Lyonnet D, Lasset C, Caron O, Mouret-Fourme E, Berthet P, Faivre L, Frenay M, Gesta P, Gladieff L, Bouhnik AD, Protière C, Noguès C.
    Genet Med; 2012 May 18; 14(5):527-34. PubMed ID: 22241105
    [Abstract] [Full Text] [Related]

  • 39. Survey of 243 ART patients having made a final disposition decision about their surplus cryopreserved embryos: the crucial role of symbolic embryo representation.
    Bruno C, Dudkiewicz-Sibony C, Berthaut I, Weil E, Brunet L, Fortier C, Pfeffer J, Ravel C, Fauque P, Mathieu E, Antoine JM, Kotti S, Mandelbaum J.
    Hum Reprod; 2016 Jul 18; 31(7):1508-14. PubMed ID: 27165623
    [Abstract] [Full Text] [Related]

  • 40. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
    Shapira M, Raanani H, Feldman B, Srebnik N, Dereck-Haim S, Manela D, Brenghausen M, Geva-Lerner L, Friedman E, Levi-Lahad E, Goldberg D, Perri T, Eldar-Geva T, Meirow D.
    Fertil Steril; 2015 Nov 18; 104(5):1162-7. PubMed ID: 26335130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 104.